For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit: www.BMSStudyConnect.com  Inclusion Criteria:  Body Mass Index (BMI) of 18.0 to 33.0 kg/m^2, inclusive. BMI = weight (kg)/(height [m])^2 Healthy based on medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram (ECG) at screening and check-in  Exclusion Criteria:  Allergy to or hypersensitive to any of the drugs or nutritional supplement used in the study Prior history of Wernicke's Encephalopathy Thiamine deficiency Hypersensitivity to ondansetron Has any medical condition, medical history, or use of concomitant medication that is contraindicated in the applicable drug labeling Has history, deviated nasal septum, and/or obstructed airway, bleeding disorders, or other inabilities for insertion of nasogastric (NG) tube (Part 2 only)  Other protocol-defined inclusion/exclusion criteria apply